Omnicell, Inc. (OMCL)
USD 44.18
(-2.28%)
USD 44.18
(-2.28%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 569.66 Million USD | -5.99% |
| 2022 | 605.97 Million USD | 1418.32% |
| 2021 | 39.91 Million USD | -92.27% |
| 2020 | 516.09 Million USD | 412.67% |
| 2019 | 100.66 Million USD | -25.66% |
| 2018 | 135.41 Million USD | -30.53% |
| 2017 | 194.91 Million USD | -20.68% |
| 2016 | 245.73 Million USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 100.0% |
| 2011 | -11.67 Million USD | -22.07% |
| 2010 | -9.56 Million USD | 1.03% |
| 2009 | -9.66 Million USD | 39.17% |
| 2008 | -15.88 Million USD | 44.46% |
| 2007 | -28.6 Million USD | 0.0% |
| 2006 | - USD | -100.0% |
| 2005 | 11.15 Million USD | 246.12% |
| 2004 | 3.22 Million USD | -35.33% |
| 2003 | 4.98 Million USD | 1534.43% |
| 2002 | 305 Thousand USD | -15.98% |
| 2001 | 363 Thousand USD | -95.67% |
| 2000 | 8.37 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 570.43 Million USD | 0.14% |
| 2024 Q3 | 603.52 Million USD | -100.0% |
| 2024 Q2 | 571.21 Million USD | 0.14% |
| 2023 Q2 | 603.62 Million USD | -0.09% |
| 2023 Q1 | 604.19 Million USD | -0.29% |
| 2023 Q4 | 569.66 Million USD | -5.33% |
| 2023 Q3 | 601.73 Million USD | -0.31% |
| 2023 FY | 569.66 Million USD | -5.99% |
| 2022 Q2 | 608.4 Million USD | 1532.3% |
| 2022 Q1 | 37.27 Million USD | -6.61% |
| 2022 Q3 | 607.66 Million USD | -0.12% |
| 2022 Q4 | 605.97 Million USD | -0.28% |
| 2022 FY | 605.97 Million USD | 1418.32% |
| 2021 FY | 39.91 Million USD | -92.27% |
| 2021 Q1 | 517.78 Million USD | 0.33% |
| 2021 Q2 | 520.06 Million USD | 0.44% |
| 2021 Q3 | 523.25 Million USD | 0.61% |
| 2021 Q4 | 39.91 Million USD | -92.37% |
| 2020 FY | 516.09 Million USD | 412.67% |
| 2020 Q1 | 48.85 Million USD | -51.47% |
| 2020 Q2 | 46.69 Million USD | -4.42% |
| 2020 Q3 | 506.48 Million USD | 984.77% |
| 2020 Q4 | 516.09 Million USD | 1.9% |
| 2019 Q1 | 154.46 Million USD | 14.06% |
| 2019 FY | 100.66 Million USD | -25.66% |
| 2019 Q2 | 131.79 Million USD | -14.67% |
| 2019 Q3 | 129.87 Million USD | -1.46% |
| 2019 Q4 | 100.66 Million USD | -22.49% |
| 2018 FY | 135.41 Million USD | -30.53% |
| 2018 Q4 | 135.41 Million USD | -18.98% |
| 2018 Q3 | 167.13 Million USD | -7.69% |
| 2018 Q2 | 181.06 Million USD | -4.95% |
| 2018 Q1 | 190.49 Million USD | -2.27% |
| 2017 Q3 | 178.92 Million USD | -2.51% |
| 2017 Q4 | 194.91 Million USD | 8.94% |
| 2017 FY | 194.91 Million USD | -20.68% |
| 2017 Q1 | 206.12 Million USD | -16.12% |
| 2017 Q2 | 183.52 Million USD | -10.97% |
| 2016 Q1 | 219.04 Million USD | 0.0% |
| 2016 Q3 | 214.83 Million USD | -0.97% |
| 2016 FY | 245.73 Million USD | 0.0% |
| 2016 Q2 | 216.93 Million USD | -0.96% |
| 2016 Q4 | 245.73 Million USD | 14.38% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | 11.62 Million USD | 198.49% |
| 2012 Q1 | -11.8 Million USD | -1.06% |
| 2012 FY | - USD | 100.0% |
| 2012 Q3 | - USD | -100.0% |
| 2011 FY | -11.67 Million USD | -22.07% |
| 2011 Q4 | -11.67 Million USD | -18.72% |
| 2011 Q3 | -9.83 Million USD | 2.2% |
| 2011 Q2 | -10.05 Million USD | 0.46% |
| 2011 Q1 | -10.1 Million USD | -5.61% |
| 2010 FY | -9.56 Million USD | 1.03% |
| 2010 Q2 | -9.8 Million USD | 2.58% |
| 2010 Q3 | -8.08 Million USD | 17.52% |
| 2010 Q4 | -9.56 Million USD | -18.26% |
| 2010 Q1 | -10.06 Million USD | -4.15% |
| 2009 Q1 | -15.65 Million USD | 0.0% |
| 2009 FY | -9.66 Million USD | 39.17% |
| 2009 Q2 | -15.7 Million USD | -0.35% |
| 2009 Q3 | -15.73 Million USD | -0.17% |
| 2009 Q4 | -9.66 Million USD | 38.55% |
| 2008 Q3 | -27.29 Million USD | 0.84% |
| 2008 FY | -15.88 Million USD | 44.46% |
| 2008 Q1 | -27.39 Million USD | 4.24% |
| 2008 Q2 | -27.52 Million USD | -0.47% |
| 2008 Q4 | - USD | 100.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q4 | -28.6 Million USD | -46.81% |
| 2007 Q3 | -19.48 Million USD | -7.44% |
| 2007 Q2 | -18.13 Million USD | 0.0% |
| 2007 FY | -28.6 Million USD | 0.0% |
| 2006 Q4 | - USD | -100.0% |
| 2006 Q3 | 1.13 Million USD | 35.94% |
| 2006 Q2 | 832 Thousand USD | -44.79% |
| 2006 FY | - USD | -100.0% |
| 2006 Q1 | 1.5 Million USD | -86.5% |
| 2005 FY | 11.15 Million USD | 246.12% |
| 2005 Q1 | 2.85 Million USD | -11.54% |
| 2005 Q2 | 2.23 Million USD | -21.67% |
| 2005 Q3 | 1.65 Million USD | -26.1% |
| 2005 Q4 | 11.15 Million USD | 575.89% |
| 2004 Q4 | 3.22 Million USD | -0.71% |
| 2004 Q3 | 3.24 Million USD | -14.71% |
| 2004 FY | 3.22 Million USD | -35.33% |
| 2004 Q2 | 3.8 Million USD | -12.52% |
| 2004 Q1 | 4.35 Million USD | -12.7% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | 4.98 Million USD | 0.0% |
| 2003 FY | 4.98 Million USD | 1534.43% |
| 2003 Q1 | - USD | -100.0% |
| 2002 Q3 | 608 Thousand USD | 0.0% |
| 2002 FY | 305 Thousand USD | -15.98% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q1 | - USD | -100.0% |
| 2002 Q4 | 305 Thousand USD | -49.84% |
| 2001 FY | 363 Thousand USD | -95.67% |
| 2001 Q4 | 363 Thousand USD | 0.0% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q2 | 6.38 Million USD | -13.44% |
| 2001 Q1 | 7.37 Million USD | 0.0% |
| 2000 FY | 8.37 Million USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 877.57 Million USD | 35.087% |
| GE HealthCare Technologies Inc. | 8.74 Billion USD | 93.487% |
| Sharecare, Inc. | 519 Thousand USD | -109661.464% |
| Progyny, Inc. | 17.24 Million USD | -3204.112% |
| Aclarion, Inc. | - USD | -Infinity% |
| CareMax, Inc. | 21.44 Million USD | -2556.634% |
| Simulations Plus, Inc. | 531 Thousand USD | -107180.979% |
| CareCloud, Inc. | 10.03 Million USD | -5575.62% |
| Forian Inc. | 22.99 Million USD | -2377.749% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 37.44 Million USD | -1421.492% |
| Definitive Healthcare Corp. | 242.56 Million USD | -134.847% |
| Zhongchao Inc. | 571.86 Thousand USD | -99515.292% |
| Accolade, Inc. | 208.48 Million USD | -173.243% |
| Streamline Health Solutions, Inc. | 9.06 Million USD | -6183.499% |
| Ontrak, Inc. | 1.46 Million USD | -38731.766% |
| SOPHiA GENETICS SA | 15.67 Million USD | -3534.671% |
| R1 RCM Inc. | 1.64 Billion USD | 65.439% |
| Spok Holdings, Inc. | 6.9 Million USD | -8153.579% |
| Privia Health Group, Inc. | 5.24 Million USD | -10758.978% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -758326.862% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 52.68 Million USD | -981.199% |
| TruBridge, Inc. | 198.34 Million USD | -187.209% |
| Nutex Health, Inc. | 26.31 Million USD | -2064.803% |
| Renalytix Plc | 4.33 Million USD | -13053.129% |
| Sharecare, Inc. | 519 Thousand USD | -109661.464% |
| Health Catalyst, Inc. | 228.03 Million USD | -149.815% |
| 10x Genomics, Inc. | 83.84 Million USD | -579.39% |
| GoodRx Holdings, Inc. | 647.7 Million USD | 12.049% |
| SCWorx Corp. | 90.35 Thousand USD | -630343.011% |
| Schrödinger, Inc. | 111.01 Million USD | -413.144% |
| HealthEquity, Inc. | 874.97 Million USD | 34.894% |
| HealthStream, Inc. | 20.24 Million USD | -2713.563% |
| MSP Recovery, Inc. | 678.98 Million USD | 16.101% |
| Augmedix, Inc. | 15.3 Million USD | -3622.551% |
| BrightSpring Health Services, Inc. Common Stock | 3.33 Billion USD | 82.903% |
| Ontrak, Inc. | 1.46 Million USD | -38731.766% |
| SHL Telemedicine Ltd. | 10.43 Million USD | -5359.638% |
| CareCloud, Inc. | 10.03 Million USD | -5575.62% |
| Premier, Inc. | 11.17 Million USD | -4999.928% |
| Certara, Inc. | 288.21 Million USD | -97.65% |
| GeneDx Holdings Corp. | 52.68 Million USD | -981.199% |
| OneMedNet Corporation | 465.02 Thousand USD | -122401.898% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.33 Billion USD | 82.903% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -758326.862% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 10.03 Million USD | -5575.62% |
| Mangoceuticals, Inc. | 64.96 Thousand USD | -876829.234% |
| CareMax, Inc. | 21.44 Million USD | -2556.634% |
| Healthcare Triangle, Inc. | 888 Thousand USD | -64051.126% |
| National Research Corporation | 29.47 Million USD | -1833.023% |
| Aclarion, Inc. | - USD | -Infinity% |
| OptimizeRx Corporation | 34.23 Million USD | -1564.183% |